Graft Versus Host Disease (GvHD) Treatment Market Analysis, 2018-2023 and 2024-2030: Corticosteroids, Hospitals, and North America Will Dominate During the Forecast Period [Yahoo! Finance]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
The graft versus host disease treatment market is expected to grow with a CAGR of 8.6% from 2024 to 2030. The major drivers for this market are increasing demand for personalized medicine, growing geriatric population, and surge in number of hematopoietic stem cell transplantation and solid organ transplantations across the globe. The future of the market looks promising with opportunities in the hospital pharmacy, online pharmacy, and retail pharmacy markets. This study includes a forecast for the global graft versus host disease treatment by product, disease type, end use, and region. Graft Versus Host Disease Treatment Market by Product [Shipment Analysis by Value from 2018 to 2030]: Corticosteroids Monoclonal Antibodies Tyrosine Kinase Inhibitors Others Graft Versus Host Disease Treatment Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]: Acute Graft-Versus-Host Disease Chronic Graft-Versus-Host Disease Graft Versus Host Disease Treatment M
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Goldman Sachs has warned its staff about sneaking off to Paris during the Olympics—and leaving the bank to pick up the tab [Yahoo! Finance]Yahoo! Finance
- Goldman Sachs has warned its staff about sneaking off to Paris during the Olympics—and leaving the bank to pick up the tab [Fortune]Fortune
- Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia APR Newswire
- Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia A [Yahoo! Finance]Yahoo! Finance
- Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia APR Newswire
SNY
Analyst Actions
- 2/12/24 - TheStreet
SNY
Sec Filings
- 4/25/24 - Form 6-K
- 4/4/24 - Form F-3ASR
- 4/4/24 - Form S-8
- SNY's page on the SEC website